Serum levels of macrophage colony-stimulating factor and aortic calcification in hemodialysis patients

被引:19
作者
Nitta, K
Akiba, T
Kawashima, A
Kimata, N
Miwa, N
Uchida, K
Honda, K
Takei, T
Otsubo, S
Yumura, W
Kabaya, T
Nihei, H
机构
[1] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjuku Ku, Tokyo 1628666, Japan
[2] Minami Senju Hosp, Dialysis Unit, Tokyo, Japan
关键词
hemodialysis; macrophage colony-stimulating factor; vascular calcification; atherosclerosis; aortic calcification index;
D O I
10.1159/000046650
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Hemodialysis (HD) patients have accelerated atherosclerosis. Recent reports have shown that aortosclerosis is more frequently observed in HD patients than in healthy subjects. Macrophage colony-stimulating factor (M-CSF) secreted by activated macrophages may be involved in the process of aortosclerosis in HD patients. To understand the mechanism behind the increased incidence of aortosclerosis in HD patients, we examined the relationships between serum M-CSF levels and aortic calcification index (ACl) estimated by CT scan. A significant increase in serum M-CSF concentrations was found in HD patients (3.8 +/- 0.2 ng/ml) as compared with controls (1.5 +/- 0.1 ng/ml). No significant differences were observed between chronic glomerulonephritis and diabetes mellitus groups of patients. We also found no significant differences between the groups using different membranes (triacetate 3.8 +/- 0.2 ng/ml vs. polysulfone 3.8 +/- 0.4 ng/ml). There was no correlation between serum M-CSF concentrations and clinical parameters such as age, duration of HD, blood pressure, serum concentrations of nitrogen, creatinine, cholesterol, triglyceride, LDL, Ca x P products, and intact parathyroid hormone. A positive correlation was observed between serum M-CSF levels and ACl in HD patients (r = 0.596, p < 0.01). These results suggest that M-CSF may be involved in the process of aortosclerosis in HD patients. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:465 / 470
页数:6
相关论文
共 34 条
[1]   CARDIAC PATHOLOGY IN PATIENTS WITH END-STAGE RENAL-DISEASE MAINTAINED ON HEMODIALYSIS [J].
ANSARI, A ;
KAUPKE, CJ ;
VAZIRI, ND ;
MILLER, R ;
BARBARI, A .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1993, 16 (01) :31-36
[2]   PLASMA INTERLEUKIN-1 ACTIVITY DURING HEMODIALYSIS - THE INFLUENCE OF DIALYSIS MEMBRANES [J].
BINGEL, M ;
LONNEMANN, G ;
KOCH, KM ;
DINARELLO, CA ;
SHALDON, S .
NEPHRON, 1988, 50 (04) :273-276
[3]   Arteriosclerosis in dialysis patients [J].
Bommer, J ;
Strohbeck, E ;
Goerich, J ;
Bahner, M ;
Zuna, I .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1996, 19 (11) :638-644
[4]   SERUM INTERLEUKIN-6 IN LONG-TERM HEMODIALYZED PATIENTS [J].
CAVAILLON, JM ;
POIGNET, JL ;
FITTING, C ;
DELONS, S .
NEPHRON, 1992, 60 (03) :307-313
[5]  
CHOLLETMARTIN S, 1991, CLIN EXP IMMUNOL, V83, P329
[6]  
CLINTON SK, 1992, AM J PATHOL, V140, P301
[7]  
DEFRANCISCO AM, 1985, Q J MED, V55, P289
[8]  
Flanagan A M, 1998, Curr Opin Hematol, V5, P181, DOI 10.1097/00062752-199805000-00006
[9]   COLONY STIMULATING FACTORS, CYTOKINES AND MONOCYTE-MACROPHAGES - SOME CONTROVERSIES [J].
HAMILTON, JA .
IMMUNOLOGY TODAY, 1993, 14 (01) :18-24
[10]   ELEVATED CIRCULATING LEVELS OF INTERLEUKIN-6 IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
HERBELIN, A ;
URENA, P ;
NGUYEN, AT ;
ZINGRAFF, J ;
DESCAMPSLATSCHA, B .
KIDNEY INTERNATIONAL, 1991, 39 (05) :954-960